Full Text
GD1 COST-UTILITY ANALYSIS OF RABEPRAZOLE AND ESOMEPRAZOLE FOR SYMPTOMATIC GASTRO OESOPHAGEAL REFLUX DISEASE

Abstract

Authors

DA Hughes D Dubois

Back to Volume 6, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×